Safety and Immunogenicity of Tdap Vaccine Compared to DTaP Vaccine in Children 4 to 6 Years of Age
Clinical trial NCT00467519 · COMPLETED
Trial details
- NCT number
- NCT00467519
- Sponsor
- Sanofi Pasteur, a Sanofi Company
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2007-04-01
- Primary completion
- 2009-11-01
- Enrollment
- 1045
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.